| BCBS Texas Medical Policies | Guselkumab | 2026-05-01 |
| BCBS Texas Medical Policies | Hematopoietic Cell Transplantation for Breast Cancer | 2026-05-01 |
| BCBS Texas Medical Policies | Hematopoietic Cell Transplantation for Epithelial Ovarian | 2026-05-01 |
| BCBS Texas Medical Policies | Hematopoietic Cell Transplantation for Non-Hodgkin | 2026-05-01 |
| BCBS Texas Medical Policies | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, | 2026-05-01 |
| BCBS Texas Medical Policies | Inebilizumab-cdon | 2026-05-01 |
| BCBS Texas Medical Policies | Natalizumab and Associated Biosimilar(s) | 2026-05-01 |
| BCBS Texas Medical Policies | Negative Pressure Wound Therapy in the Outpatient Setting | 2026-05-01 |
| BCBS Texas Medical Policies | Nerve Graft with Radical Prostatectomy | 2026-05-01 |
| BCBS Texas Medical Policies | Noncontact Normothermic Wound Therapy (NNWT) | 2026-05-01 |